Author/Authors :
Shindler، نويسنده , , Daniel M. and Kostis، نويسنده , , John B. and Yusuf، نويسنده , , Salim and Quinones، نويسنده , , Miguel A. and Pitt، نويسنده , , Bertram and Stewart، نويسنده , , Dawn and Pinkett، نويسنده , , Tamara and Ghali، نويسنده , , Jalal K. and Wilson، نويسنده , , Alan C. and The SOLVD Investigators، نويسنده ,
Abstract :
Diabetes is an independent predictor of morbidity and mortality in patients with symptomatic heart failure, patients with asymptomatic left ventricular dysfunction (defined as an ejection fraction of 35% or less), and in a broader registry population with less stringent entry criteria. Although the SOLVD Trials made a major clinical contribution by proving the value of enalapril, diabetes remains a significant predictor of outcome even after adjusting for treatment with enalapril.
